4
J. Lee et al. / Tetrahedron xxx (2013) 1e5
catalyst was washed successively with 10 mL of water, ethanol,
ethyl acetate, dichloromethane, and hexanes, and then dried. In
a typical recycling experiment, more than 98% of PdeFe3O4 could
be recovered.
3H); 13C NMR (100 MHz, CDCl3)
d 159.8,146.0,132.2,129.8,125.7,124.1,
123.5, 121.8, 118.4, 114.9, 112.5, 55.6.
4.6.8. 3-Imidazo[1,2-a]pyridine-3-ylbenzonitrile (3h).11f Yield (94%)
from 1 and 3-bromobenzonitrile (2h). 1H NMR (400 MHz, CDCl3)
4.5. General procedure for the Pd-catalyzed CeH arylation
d
8.27 (dd, J¼6.9, 1.1 Hz, 1H), 7.83 (s, 1H), 7.80e7.75 (m, 1H), 7.72 (s,
1H), 7.70e7.57 (m, 3H), 7.25e7.18 (m, 1H), 6.90e6.83 (m, 1H); 13C
NMR (100 MHz, CDCl3) 146.8, 133.7, 132.0, 131.5, 131.0, 130.9,
In DMA (2 mL) degassed by a stream of argon gas for 10 min
were dissolved aryl bromide 2 (0.5 mmol), imidazo[1,2-a]pyridine
(1, 0.0886 g, 0.75 mmol), NaOAc (0.0821 g, 1 mmol), and PdeFe3O4
(0.0217 g, 0.005 mmol). The resulting suspension was degassed by
argon for 10 min, sonicated for 3 min, and stirred at 166 ꢀC for 12 h.
After cooled to room temperature, the reaction mixture was filtered
with a short silica gel pad and concentrated under reduced pres-
sure. Alternatively, the reaction mixture was concentrated after
magnetic separation of PdeFe3O4. The crude product was purified
by flash column chromatography on a silica gel column.
d
130.4, 125.1, 123.5, 123.0, 118.7, 118.4, 113.7, 113.4.
4.6.9. 3-Imidazo[1,2-a]pyridin-3-ylbenzaldehyde (3i).11f Yield (74%)
from 1 and 3-bromobenzaldehyde (2i). 1H NMR (400 MHz, CDCl3)
d
10.05 (s, 1H), 8.30 (dd, J¼6.9, 1.0 Hz,1H), 8.04 (t, J¼1.4 Hz,1H), 7.87
(dt, J¼7.6, 1.3 Hz, 1H), 7.82e7.75 (m, 1H), 7.72 (s, 1H), 7.68e7.60 (m,
2H), 7.24e7.14 (m, 1H), 6.82 (td, J¼6.9, 1.0 Hz, 1H); 13C NMR
(100 MHz, CDCl3)
d 191.8, 146.6, 137.3, 133.7, 133.3, 130.5, 130.2,
129.6, 128.3, 124.9, 124.4, 123.2, 118.5, 113.2.
4.6. Characterization of the arylation products
4.6.10. 3-Naphthalene-2-yl-imidazo[1,2-a]pyridine (3j).11f Yield (75%)
from 1 and 2-bromonaphthalene (2j). 1H NMR (400 MHz, CDCl3)
4.6.1. 3-(4-Nitrophenyl)-imidazo[1,2-a]pyridine (3a).14 Yield (88%)
from 1 and 4-bromonitrobenzene (2a). 1H NMR (400 MHz, CDCl3)
d
8.44 (d, J¼7.0 Hz, 1H), 8.03 (s, 1H), 7.98 (d, J¼8.5 Hz, 1H), 7.93e7.87
(m, 2H), 7.81 (s, 1H), 7.71 (d, J¼9.1 Hz, 1H), 7.67 (dd, J¼8.5,1.7 Hz, 1H),
7.59e7.51 (m, 2H), 7.23 (ddd, J¼9.1, 6.7, 1.2 Hz, 1H), 6.84 (td, J¼6.8,
d
8.42 (d, J¼7.0 Hz, 1H), 8.38 (d, J¼8.7 Hz, 2H), 7.86 (s, 1H), 7.81e7.69
(m, 3H), 7.30 (ddd, J¼8.6, 6.8, 0.7 Hz, 1H), 6.94 (t, J¼6.6 Hz, 1H); 13
C
1.1 Hz, 1H); 13C NMR (100 MHz, CDCl3)
d 146.5, 133.8, 133.2, 133.0,
NMR (100 MHz, CDCl3)
d
147.5, 147.0,136.1,134.9,127.7, 125.6,125.0,
129.2, 128.2, 128.1, 127.0, 126.89, 126.87, 126.7, 126.0, 124.5, 123.6,
118.6, 112.9.
123.9, 123.4, 119.0, 113.8.
4.6.2. 4-Imidazo[1,2-a]pyridine-3-ylbenzonitrile (3b).11f Yield (95%)
from 1 and 4-bromobenzonitrile (2b). 1H NMR (400 MHz, CDCl3)
4.6.11. 3-Naphthalene-1-yl-imidazo[1,2-a]pyridine (3k).15 Yield (70%)
from 1 and 1-bromonaphthalene (2k). 1H NMR (400 MHz, CDCl3)
d
8.37 (dt, J¼7.0, 1.1 Hz,1H), 7.86e7.76 (m, 3H), 7.71 (qt, J¼2.1, 1.4 Hz,
d
7.98 (dt, J¼16.0, 6.3 Hz, 2H), 7.80 (s, 1H), 7.74 (d, J¼9.1 Hz, 1H), 7.71
3H), 7.32e7.23 (m, 1H), 6.90 (td, J¼6.9, 1.2 Hz, 1H); 13C NMR
(d, J¼6.9 Hz, 1H), 7.62e7.56 (m, 2H), 7.55e7.47 (m, 2H), 7.46e7.38 (m,
(100 MHz, CDCl3)
123.3, 118.9, 118.8, 113.6, 111.4.
d 147.3, 134.4, 134.2, 133.3, 127.9, 125.4, 124.2,
1H), 7.21 (tt, J¼17.6, 6.1 Hz, 1H), 6.69 (t, J¼6.8 Hz, 1H); 13C NMR
(100 MHz, CDCl3) d 146.0, 134.1, 134.0, 132.2, 129.8, 129.3, 128.9, 127.1,
126.6, 126.4, 125.8, 125.4, 124.5, 124.3, 118.2, 112.5.
4.6.3. 4-Imidazo[1,2-a]pyridin-3-ylbenzaldehyde (3c).11f Yield (82%)
from 1 and 4-bromobenzaldehyde (2c). 1H NMR (400 MHz, CDCl3)
4.6.12. 3-Anthracen-9-ylimidazo[1,2-a]pyridine (3l).11f Yield (58%)
from 1 and 9-bromoanthracene (2l). 1H NMR (400 MHz, CDCl3)
d
10.07 (s, 1H), 8.44 (d, J¼6.9 Hz, 1H), 8.04 (t, J¼9.9 Hz, 2H), 7.84 (s,
1H), 7.77 (d, J¼8.1 Hz, 2H), 7.72 (d, J¼9.1 Hz, 1H), 7.34e7.21 (m, 1H),
d
8.49 (s, 1H), 7.96 (d, J¼8.4 Hz, 2H), 7.80 (s, 1H), 7.71 (d, J¼9.1 Hz,
6.91 (t, J¼6.7 Hz, 1H); 13C NMR (100 MHz, CDCl3)
d
191.5, 147.2,
1H), 7.42 (d, J¼8.7 Hz, 2H), 7.39e7.32 (m, 2H), 7.27e7.20 (m, 2H),
135.5, 134.4, 130.8, 127.7, 125.2, 124.7, 123.5, 118.8, 113.4.
7.17 (t, J¼6.9 Hz, 1H), 7.14e7.06 (m, 1H), 6.47 (t, J¼6.7 Hz, 1H); 13C
NMR (100 MHz, CDCl3)
d 146.1, 135.6, 133.6, 131.9, 131.6, 129.3,
4.6.4. 4-Imidazo[1,2-a]pyridin-3-ylacetophenone (3d).11f Yield (94%)
from 1 and 4-bromoacetophenone (2d). 1H NMR (400 MHz, CDCl3)
128.9, 126.9, 125.7, 124.5, 124.2, 122.1, 120.8, 118.1, 112.4.
d
8.42 (d, J¼7.0 Hz, 1H), 8.11 (d, J¼8.3 Hz, 2H), 7.81 (s, 1H), 7.74e7.65
Acknowledgements
(m, 3H), 7.29e7.22 (m, 1H), 6.89 (t, J¼6.8 Hz, 1H), 2.67 (s, 3H); 13C
NMR (100 MHz, CDCl3)
127.5, 125.0, 124.9, 123.5, 118.7, 113.3, 26.8.
d 197.4, 147.0, 136.3, 134.2, 134.0, 129.5,
Support for this work was provided through the BRL (Basic
Research Laboratory) program of the NRF (National Research
Foundation) of Korea.
4.6.5. 3-(4-Chlorophenyl)-imidazo[1,2-a]pyridine (3e).11e Yield (67%)
from 1 and 1-bromo-4-chlorobenzene (2e). 1H NMR (400 MHz,
Supplementary data
CDCl3)
d
8.27 (d, J¼7.0 Hz, 1H), 7.67 (d, J¼10.6 Hz, 2H), 7.49 (s, 4H),
7.21 (ddd, J¼9.0, 6.7, 1.1 Hz,1H), 6.82 (td, J¼6.9, 0.8 Hz, 1H); 13C NMR
1H and 13C NMR spectra for all compounds. Supplementary data
(100 MHz, CDCl3)
d 146.4, 134.2, 134.2, 133.0, 129.7, 129.4, 128.0,
124.6, 123.3, 118.6, 113.0.
4.6.6. 3-(4-Methylphenyl)-imidazo[1,2-a]pyridine (3f).15 Yield (81%)
References and notes
from 1 and 4-bromotoluene (2f). 1H NMR (400 MHz, CDCl3)
d 8.31
(d, J¼7.0 Hz, 1H), 7.66 (d, J¼8.2 Hz, 2H), 7.45 (d, J¼7.1 Hz, 2H), 7.32
1. (a) Nicolaou, K. C.; Baulger, P. G.; Sarlah, D. Angew. Chem., Int. Ed. 2005, 44, 4442;
(b) Hughes, R. A.; Moody, C. Angew. Chem., Int. Ed. 2007, 46, 7930; (c) Kim, O.;
Jeong, Y.; Lee, H.; Hong, S.-S.; Hong, S. J. Med. Chem. 2011, 54, 2455; (d) Wan, J.;
Zheng, C.-J.; Fung, M.-K.; Liu, X.-K.; Lee, C.-S.; Zhang, X.-H. J. Mater. Chem. 2012,
22, 4502.
(d, J¼7.7 Hz, 2H), 7.18 (dd, J¼8.4, 7.3 Hz, 1H), 6.79 (t, J¼6.8 Hz, 1H),
2.43 (s, 3H); 13C NMR (100 MHz, CDCl3)
d 146.2, 138.3, 132.5, 130.1,
128.2, 126.5, 125.9, 124.2, 123.5, 118.4, 112.6, 21.5.
2. Li, J. J.; Gribble, G. W. Palladium in Heterocyclic Chemistry; Pergamon: Am-
sterdam, The Netherlands, 2000.
3. (a) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107, 174; (b) Seregin, I.
V.; Gevorgyan, V. Chem. Soc. Rev. 2007, 36, 1173; (c) Ackermann, L.; Vicente, R.;
Kapdi, A. R. Angew. Chem., Int. Ed. 2009, 48, 9792; (d) Bellina, F.; Rossi, R. Tet-
rahedron 2009, 65, 10269; (e) Chiusoli, G. P.; Catellani, M.; Costa, M.; Motti, E.;
4.6.7. 3-(4-Methoxylphenyl)-imidazo[1,2-a]pyridine (3g).15 Yield (42%)
from 1 and 4-bromoanisole (2g). 1H NMR (400 MHz, CDCl3)
d 8.26 (d,
J¼6.9 Hz, 1H), 7.68e7.61 (m, 2H), 7.50e7.44 (m, 2H), 7.17 (ddd, J¼9.0,
6.7, 1.1 Hz, 1H), 7.09e7.02 (m, 2H), 6.79 (td, J¼6.8, 0.9 Hz, 1H), 3.88 (s,